Sign In
Buy WGS
$53.02
-0.110 (-0.207%)
At Close: Jun 03, 2026
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025
08:30am, Monday, 05'th Jan 2026
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx announced a record-setting year for its research programs, reinforcing its position as the global leader in rare disease genomics.
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference
08:00am, Tuesday, 30'th Dec 2025
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx announced that company management will participate in the 44th Annual J.P. Morgan Healthcare Conference from January 12-15 in San Francisco.
Financial Analysis: GeneDx (NASDAQ:WGS) & Todos Med (OTCMKTS:TOMDF)
02:35am, Sunday, 28'th Dec 2025
Todos Med (OTCMKTS:TOMDF - Get Free Report) and GeneDx (NASDAQ: WGS - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the
Assenagon Asset Management S.A. Has $1.52 Million Stock Position in GeneDx Holdings Corp. $WGS
03:19am, Thursday, 25'th Dec 2025
Assenagon Asset Management S.A. lowered its stake in GeneDx Holdings Corp. (NASDAQ: WGS) by 70.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Com
GeneDx (NASDAQ:WGS) CFO Sells $554,618.85 in Stock
05:18am, Sunday, 21'st Dec 2025
GeneDx Holdings Corp. (NASDAQ: WGS - Get Free Report) CFO Kevin Feeley sold 3,855 shares of the stock in a transaction dated Tuesday, December 16th. The shares were sold at an average price of $143.87
Katherine Stueland Sells 10,857 Shares of GeneDx (NASDAQ:WGS) Stock
04:30am, Saturday, 20'th Dec 2025
GeneDx Holdings Corp. (NASDAQ: WGS - Get Free Report) CEO Katherine Stueland sold 10,857 shares of the business's stock in a transaction that occurred on Tuesday, December 16th. The stock was sold at
GAITHERSBURG, Md.--(BUSINESS WIRE)--The GUARDIAN study has been recognized as one of the most impactful scientific contributions published across all JAMA journals this year.
Cim LLC Purchases New Shares in GeneDx Holdings Corp. $WGS
04:08am, Monday, 15'th Dec 2025
Cim LLC bought a new position in GeneDx Holdings Corp. (NASDAQ: WGS) during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 4,770 shares of the
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Rating of “Moderate Buy” from Analysts
01:46am, Monday, 15'th Dec 2025
GeneDx Holdings Corp. (NASDAQ: WGS - Get Free Report) has earned a consensus rating of "Moderate Buy" from the eleven brokerages that are covering the company, Marketbeat reports. One analyst has rate
Ardsley Advisory Partners LP Takes $7.39 Million Position in GeneDx Holdings Corp. $WGS
03:28am, Wednesday, 10'th Dec 2025
Ardsley Advisory Partners LP purchased a new position in shares of GeneDx Holdings Corp. (NASDAQ: WGS) in the second quarter, according to its most recent filing with the SEC. The firm purchased 80,00
GeneDX CEO Sells 2,158 Shares After 84% One-Year Bump
09:03am, Tuesday, 09'th Dec 2025
GeneDX provides an artificial intelligence-powered genetic testing platform. CEO Katherine Stueland sold about $300,000 worth of shares on Oct. 29.
TSLA: Cathie Wood Dumps Millions in Tesla and Meta Shares
10:11am, Friday, 05'th Dec 2025
Cathie Wood shifted several positions across her ARK ETFs on Dec. 4, moving money out of two Mega tech names and into mid-cap growth stocks.ARK sold 14,211 shar
HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
03:20pm, Sunday, 30'th Nov 2025
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Nov. 30, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is inve
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit?
01:51pm, Friday, 14'th Nov 2025
Sold 69,858 shares, reducing stake value by about $6.45 million Post-trade stake in GeneDx Holdings Corp: zero shares, $0 value The position previously comprised 1.9% of the fund's AUM as of the prior
Artificial Intelligence (AI) Stock Scores Vote of Confidence From Asset Manager, According to Recent Filing
09:58am, Tuesday, 11'th Nov 2025
Added 120,000 shares of GeneDx Holdings, an increase valued at ~$12.93 million Post-trade stake: 120,000 shares worth $12.93 million as of September 30, 2025 GeneDx Holdings is not among Telemark Asse
